Association between sodium intakes with the risk of chronic kidney disease: Evidence from a meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 11, 2015, Pages 20939-20945

  Liu, Nian ^a   Sun, Weixia ^a   Xing, Zhiwen ^a   Ma, Fuzhe ^a   Sun, Tao ^a   Wu, Hao ^a   Dong, Yijun ^a   Xu, Zhonggao ^a   Fu, Yaowen ^a   Yuan, Hang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Meta analysis; Sodium

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; EUROPE; GLOMERULUS FILTRATION RATE; HUMAN; META ANALYSIS; PUBLICATION; RISK; SODIUM INTAKE;

EID: 84954311060     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM and Williamson DF. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 1868-1874.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS and Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
3. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS and Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011; 305: 2532-2539.
4. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ and Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004; 44: 398-404.
5. Hajjar I and Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
6. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D and Psaty B. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005; 293: 1737-1745.
7. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E and Zucchelli P. Effect of the angiotensin-convertingenzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996; 334: 939-945.
8. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP and Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359-364.
9. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
10. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004; 43: 142-146.
11. DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
12. Higgins JP and Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
13. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
14. Higgins JP and Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-1682.
15. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
16. Tobias A. Assessing the in fluence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 47: 15-17.
17. Crews DC, Kuczmarski MF, Miller ER 3rd, Zonderman AB, Evans MK and Powe NR. Dietary Habits, Poverty, and Chronic Kidney Disease in an Urban Population. J Ren Nutr 2015; 25: 103-10.
18. Fan L, Tighiouart H, Levey AS, Beck GJ and Sarnak MJ. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int 2014; 86: 582-588.
19. Humalda JK and Navis G. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens 2014; 23: 533-540.
20. Koo HS, Kim YC, Ahn SY, Oh SW, Kim S and Chin HJ. Analysis of correlation between 24-hour urinary sodium and the degree of blood pressure control in patients with chronic kidney disease and non-chronic kidney disease. J Korean Med Sci 2014; 29 Suppl 2: S117-122.
21. McQuarrie EP, Traynor JP, Taylor AH, Freel EM, Fox JG, Jardine AG and Mark PB. Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease. Hypertension 2014; 64: 111-117.
22. Nerbass FB, Pecoits-Filho R, McIntyre NJ, Mc-Intyre CW and Taal MW. High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients. Eur J Clin Nutr 2015; 69: 786-90.
23. Ortega O, Cobo G, Rodriguez I, Camacho R, Gallar P, Mon C, Herrero JC, Ortiz M, Oliet A, Di Gioia C and Vigil A. Lower Plasma Sodium Is Associated with a Microinflammatory State among Patients with Advanced Chronic Kidney Disease. Nephron Clin Pract 2014; 28: 312-8.
24. Sharma S, McFann K, Chonchol M, de Boer IH and Kendrick J. Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study. Am J Nephrol 2013; 37: 526-533.
25. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Waden J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane Study Group. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011; 34: 861-866.
26. Barton M, Vos I, Shaw S, Boer P, D'Uscio LV, Grone HJ, Rabelink TJ, Lattmann T, Moreau P and Luscher TF. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis. J Am Soc Nephrol 2000; 11: 835-845.
27. Meng S, Roberts LJ 2nd, Cason GW, Curry TS and Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and-resistant rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: R732-738.
28. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ and Wilcox CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003; 14: 2775-2782.
29. Weir MR, Dengel DR, Behrens MT and Goldberg AP. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25: 1339-1344.
30. Suckling RJ, He FJ and Macgregor GA. Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev 2010; CD006763.
31. Munafo MR and Flint J. Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444.
32. Prentice RL. Dietary assessment and the reliability of nutritional epidemiology reports. Lancet 2003; 362: 182-183.